Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis

Journal of Clinical Investigation

Volumn 104, Issue 9, 1999, Pages 1181-1189

  Travers, Jeffrey B ^a   Hamid, Qutayba A ^b   Norris, David A ^c   Kuhn, Christine ^a   Giorno, Ralph C ^c   Schlievert, Patrick M ^d   Farmer, Evan R ^a   Leung, Donald Y M ^c,e  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN B; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; CELLULAR IMMUNITY; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; LICHEN PLANUS; MAJOR CLINICAL STUDY; PATCH TEST; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; SKIN INFLAMMATION;

EID: 0032741969     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6835     Document Type: Article

References (45)

1. Nickoloff, B.J. 1991. The cytokine network in psoriasis. Arch. Dermatol. 127:871-884.
2. Leung, D.Y.M., et al. 1993. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J. Clin. Invest. 92:1374-1380.
3. Henderson, C.A., and Highet, A.S. 1988. Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections. Br. J. Dermatol. 118:559-561.
4. Leung, D.Y.M., Walsh, P., Giorno, R., and Norris, D.A. 1993. A potential role for superantigens in the pathogenesis of psoriasis. J. Invest. Dermatol. 100:225-228.
5. Leung, D.Y.M., et al. 1995. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J. Clin. Invest. 96:2106-2112.
6. Kappler, J., et al. 1989. V beta-specific stimulation of human T cells by staphylococcal toxins. Science. 244:811-813.
7. Choi, Y.W., et al. 1989. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. USA. 86:8941-8945.
8. Kotzin, B.L., Leung, D.Y.M., Kappler, J., and Marrack, P. 1993. Superantigens and their potential role in human disease. Adv. Immunol. 54:99-166.
9. Nickoloff, B.J., et al. 1993. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. J. Immunol. 150:2148-2159.
10. Tokura, Y., et al. 1994. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J. Invest. Dermatol. 102:31-38.
11. Rich, R.R., Mollick, J.A., and Cook, R.G. 1989. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules. Trans. Am. Clin. Climatol. Assoc. 101:195-204.
12. Lewis, H.M., et al. 1993. Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br. J. Dermatol. 129:514-520.
13. Boehncke, W.H., Dressel, D., Zollner, T.M., and Kaufmann, R. 1996. Pulling the trigger on psoriasis [letter]. Nature. 379:777.
14. Wrone-Smith, T., and Nickoloff, B.J. 1996. Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. 98:1878-1887.
15. Henseler, T., and Christophers, E. 1985. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J. Am. Acad. Dermatol. 13:450-456.
16. Hanifin, J.M., and Rajka, G. 1980. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. Suppl. (Stockh.) 92:44-47.
17. Blomster-Hautamaa, D.A., and Schlievert, P.M. 1988. Preparation of toxic shock syndrome toxin-1. Methods Enzymol. 165:37-43.
18. Murray, D.L., et al. 1996. Localization of biologically important regions on toxic shock syndrome toxin 1. Infect. Immun. 64:371-374.
19. Hurley, J.M., et al. 1995. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. J. Exp. Med. 181:2229-2235.
20. Ying, S., et al. 1994. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology. 82:200-206.
21. Hamid, Q., Boguniewicz, M., and Leung, D.Y.M. 1994. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94:870-876.
22. Frew, A.J., and Kay, A.B. 1988. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J. Immunol. 141:4158-4164.
23. Nickoloff, B.J., and Naidu, Y. 1994. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol. 30:535-546.
24. Ezepchuk, Y.V., et al. 1996. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J. Invest. Dermatol. 107:603-609.
25. Wikner, N.E., et al. 1986. Study of HLA-DR synthesis in cultured human keratinocytes. J. Invest. Dermatol. 87:559-564.
26. Vallat, V.P., et al. 1994. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J. Exp. Med. 180:283-296.
27. Christophers, E., and Sterry, W. 1993. Psoriasis. In Dermatology in general medicine. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, and K.F. Austen, editors. McGraw-Hill, New York, NY. 489-514.
28. Nickoloff, B.J., and Wrone-Smith, T. 1998. Superantigens, autoantigens, and pathogenic T cells in psoriasis [letter]. J. Invest. Dermatol. 110:459-460.
29. Strange, P., Skov, L., Lisby, S., Nielsen, P.L., and Baadsgaard, O. 1996. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch. Dermatol. 132:27-33.
30. Koebner, J. 1877. Zur aetiologie der psoriasis. Vjscher. Derm. 4:203-207.
31. Eddy, D., Ascheim, E., and Farber, E.M. 1964. Experimental analysis of isomorphic (Koebner) response in psoriasis. Arch. Dermatol. 89:579-588.
32. Heng, M.C., Kloss, S.G., Kuehn, C.S., and Chase, D.G. 1985. The sequence of events in psoriatic plaque formation after tape-stripping. Br. J. Dermatol. 112:517-532.
33. Pinkus, H. 1951. Examination of epidermis by the strip method II. Biometric data on regeneration of the human epidermis. J. Invest. Dermatol. 19:431-447.
34. Wood, L.C., Jackson, S.M., Elias, P.M., Grunfeld, C., and Feingold, K.R. 1992. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J. Clin. Invest. 90:482-487.
35. Arndt, K. 1993. Lichen planus. In Dermatology in general medicine. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, and K.F. Austen, editors. McGraw-Hill, New York, NY. 1134-1144.
36. Esgleyes-Ribot, T., Chandraratna, R.A., Lew-Kaya, D.A., Sefton, J., and Duvic, M. 1994. Response of psoriasis to a new topical retinoid, AGN 190168. J. Am. Acad. Dermatol. 30:581-590.
37. Paukkonen, K., Naukkarinen, A., and Horsmanheimo, M. 1995. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Arch. Dermatol. Res. 287:165-170.
38. Farthing, P.M., Matear, P., and Cruchley, A.T. 1992. Langerhans cell distribution and keratinocyte expression of HLADR in oral lichen planus. J. Oral Pathol. Med. 21:451-455.
39. Volc-Platzer, B., Groh, V., and Wolff, K. 1987. Differential expression of class II alloantigens by keratinocytes in disease. J. Invest. Dermatol. 89:64-68.
40. Rosenberg, E.W., et al. 1986. Use of rifampin with penicillin and erythromycin in the treatment of psoriasis. Preliminary report. J. Am. Acad. Dermatol. 14:761-764.
41. Schmitt-Egenolf, M., Boehncke, W.H., Christophers, E., Stander, M., and Sterry, W. 1991. Type I and type II psoriasis show a similar usage of T-cell receptor variable regions. J. Invest. Dermatol. 97:1053-1056.
42. Boehncke, W.H., et al. 1995. T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated V beta regions. J. Invest. Dermatol. 104:725-728.
43. Jeffes, E.W., III, et al. 1995. Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity. J. Invest. Dermatol. 105:733-738.
44. Yokote, R., Tokura, Y., Furukawa, F., and Takigawa, M. 1995. Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis. Arch. Dermatol. Res. 287:443-447.
45. Barker, J.N., and MacDonald, D.M. 1987. Epidermal class II human lymphocyte antigen expression in atopic dermatitis: a comparison with experimental allergic contact dermatitis. J. Am. Acad. Dermatol. 16:1175-1179.